Advertisement
ABEO vs ACET
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABEO is a Hold and ACET is a StrongBuy.
ABEO sees its 50-day moving average cross bearishly below its 200-day moving average
The 50-day moving average for ABEO moved below the 200-day moving average on October 21, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for ABEO turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 33 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABEO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ABEO entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ABEO's RSI Indicator exited the oversold zone, 28 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 60 cases where ABEO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
Following a +2.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where ABEO advanced for three days, in 212 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
ABEO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.996) is normal, around the industry mean (2.973). P/E Ratio (-3.694) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (13.089) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. ABEO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ACET in upward trend: price may jump up because it broke its lower Bollinger Band on September 28, 2026
ACET may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 27 of 30 cases where ACET's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +12.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACET advanced for three days, in 239 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Bearish Trend Analysis
ACET moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ACET crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.
The 50-day moving average for ACET moved below the 200-day moving average on October 21, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for ACET entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.334) is normal, around the industry mean (2.973). P/E Ratio (-0.411) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. ACET’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACET’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ABEO | ACET | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 57 | 52 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 30 Undervalued | 47 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 98 | |
PRICE GROWTH RATING 1..100 | 79 | 93 | |
P/E GROWTH RATING 1..100 | 98 | 10 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ABEO's Valuation (30) in the Pharmaceuticals Generic industry is in the same range as ACET (47) in the Medical Distributors industry. This means that ABEO’s stock grew similarly to ACET’s over the last 12 months.
ABEO's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as ACET (100) in the Medical Distributors industry. This means that ABEO’s stock grew similarly to ACET’s over the last 12 months.
ABEO's SMR Rating (98) in the Pharmaceuticals Generic industry is in the same range as ACET (98) in the Medical Distributors industry. This means that ABEO’s stock grew similarly to ACET’s over the last 12 months.
ABEO's Price Growth Rating (79) in the Pharmaceuticals Generic industry is in the same range as ACET (93) in the Medical Distributors industry. This means that ABEO’s stock grew similarly to ACET’s over the last 12 months.
ACET's P/E Growth Rating (10) in the Medical Distributors industry is significantly better than the same rating for ABEO (98) in the Pharmaceuticals Generic industry. This means that ACET’s stock grew significantly faster than ABEO’s over the last 12 months.
| ABEO | ACET | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 82% |
| Stochastic ODDS (%) | 1 day ago 87% | 1 day ago 86% |
| Momentum ODDS (%) | N/A | N/A |
| MACD ODDS (%) | 1 day ago 75% | N/A |
| TrendWeek ODDS (%) | 1 day ago 79% | 1 day ago 88% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 89% |
| Advances ODDS (%) | 18 days ago 83% | 23 days ago 84% |
| Declines ODDS (%) | 1 day ago 84% | 1 day ago 88% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 74% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABEO’s FA Score shows that 1 FA rating(s) are green while ACET’s FA Score has 1 green FA rating(s).
- ABEO’s FA Score: 1 green, 4 red.
- ACET’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABEO’s TA Score shows that 4 TA indicator(s) are bullish while ACET’s TA Score has 4 bullish TA indicator(s).
- ABEO’s TA Score: 4 bullish, 4 bearish.
- ACET’s TA Score: 4 bullish, 5 bearish.
Price Growth
ABEO (@Biotechnology) experienced а -3.87% price change this week, while ACET (@Biotechnology) price change was -8.18% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.
Reported Earning Dates
ABEO is expected to report earnings on Nov 11, 2026.
ACET is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Biotechnology (-1.17% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ACET and
Correlation & Price change
A.I.dvisor indicates that over the last year, ACET has been loosely correlated with VIR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then VIR could also see price increases.
| Ticker / NAME | Correlation To ACET | 1D Price Change % | ||
|---|---|---|---|---|
| ACET | 100% | -4.68% | ||
| VIR - ACET | 43% Loosely correlated | -1.32% | ||
| OGI - ACET | 41% Loosely correlated | -0.43% | ||
| RXRX - ACET | 40% Loosely correlated | -1.65% | ||
| ABEO - ACET | 38% Loosely correlated | -0.89% | ||
| EDIT - ACET | 37% Loosely correlated | -0.80% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| UPW | 20.96 | 0.73 | +3.61% |
| ProShares Ultra Utilities (UPW) | |||
| IROC | 48.66 | 0.42 | +0.87% |
| Invesco Rochester High Yield Municipal ETF | |||
| PMIO | 49.88 | 0.41 | +0.82% |
| PGIM Municipal Income Opportunities ETF (PMIO) | |||
| IBMP | 25.30 | N/A | N/A |
| iShares iBonds Dec 2027 Term Muni Bond ETF (IBMP) | |||
| XBI | 151.64 | -1.14 | -0.75% |
| State Street SPDR S&P Biotech ETF (XBI) | |||